The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to
Read MoreTag: Eli
Eli Lilly Stock: Is LLY Stock A Buy After Mounjaro Drives A Strong Third-Quarter Beat?
Eli Lilly (LLY) stock retook its 50-day moving average in early November after diabetes drug, Mounjaro, helped drive a third-quarter beat. X Before yearend, analysts
Read More